Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.19.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash $ 1,414,792 $ 119,136
Prepaid expenses 312,842
Total Current Assets 1,727,634 119,136
Security deposit 23,800 23,800
Deferred offering costs 182,742
Cash and marketable securities held in Trust Account 300,347,116
Total Assets 302,098,550 325,678
Current liabilities    
Accounts payable and accrued expenses 79,989 20,222
Accrued offering costs 1,699 25,149
Promissory note – related party 299,000
Total Current Liabilities 81,688 344,371
Deferred tax liability 1,366
Deferred underwriting fee payable 10,505,250
Total Liabilities 10,588,304 344,371
Commitments and Contingencies (Note 6)
Common stock subject to possible redemption, 28,636,988 shares at redemption value as of March 31, 2019 286,510,242
Stockholders' Equity (Deficit)    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding
Common stock, Value
Additional paid in capital 5,084,230 24,250
Accumulated deficit (85,114) (43,693)
Total Stockholders’ Equity (Deficit) 5,000,004 (18,693)
Total Liabilities and Stockholders’ Equity (Deficit) 302,098,550 325,678
Class A Common Stock    
Stockholders' Equity (Deficit)    
Common stock, Value 138
Total Stockholders’ Equity (Deficit) 138
Class B Common Stock    
Stockholders' Equity (Deficit)    
Common stock, Value 750 750
Total Stockholders’ Equity (Deficit) $ 750 $ 750